Tokyo, Mar 5, 2007 (JCN Newswire) - Eisai Co., Ltd. (TSE: 4523) announced today that the Company established its pharmaceutical manufacturing subsidiary "Eisai Manufacturing Ltd."(EML) in Hatfield, United Kingdom. EML is owned by the Company's European regional headquarters, Eisai Europe Limited (Headquarters: London, President: Yutaka Tsuchiya).
